OCULAR THERAPEUTIX, INC (OCUL)

Latest Insider Confidence Score

2026Q1

48.7
Bearish

Company insider confidence (by quarter)

2014Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Summer Road Llc 10% Owner 8,591,401 Feb 27, 2024
Opaleye Management Inc. 10% Owner 5,122,500 Apr 3, 2020
Mattessich Antony C. CEO 446,281 Feb 8, 2023
Notman Donald COO 308,807 Sep 4, 2025
Dugel Pravin Officer 300,115 Nov 26, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 23, 2026 Feb 25, 2026 Dugel Pravin Officer Sell 45.0 -20,056 -0.60% ✗ $166.1K
Feb 23, 2026 Feb 25, 2026 Kaiser Peter Chief Development Officer Sell 46.3 -2,810 -1.03% ✗ $23.3K
Feb 23, 2026 Feb 25, 2026 Heier Jeffrey S. Chief Scientific Officer Sell 48.8 -3,057 -0.94% ✗ $25.3K
Feb 23, 2026 Feb 25, 2026 Nayak Sanjay Chief Strategy Officer Sell 48.8 -1,759 -0.53% ✗ $14.6K
Feb 20, 2026 Feb 24, 2026 Waheed Nadia Chief Medical Officer Sell 46.3 -3,510 -1.10% ✗ $27.2K
Feb 20, 2026 Feb 24, 2026 LINDSTROM RICHARD L MD Director Buy 97.5 +60,229 32.26% ✗ $461.4K
Feb 12, 2026 Feb 17, 2026 Notman Donald COO Sell 42.5 -11,446 -3.03% ✗ $103.5K
Feb 12, 2026 Feb 17, 2026 Nayak Sanjay Chief Strategy Officer Sell 42.5 -10,348 -3.02% ✗ $93.5K
Feb 12, 2026 Feb 17, 2026 Dugel Pravin Officer Sell 37.5 -124,882 -3.61% ✗ $1.1M
Feb 12, 2026 Feb 17, 2026 Waheed Nadia Chief Medical Officer Sell 42.5 -7,863 -2.41% ✗ $71.1K
Feb 2, 2026 Feb 4, 2026 Notman Donald COO Sell 42.5 -11,490 -2.95% ✗ $101.4K
Jan 21, 2026 Jan 26, 2026 Robinson David Wayne Global CCO Neutral 90.0 +136,000 100.00% ✗ -
Jan 26, 2026 Robinson David Wayne Global CCO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2026 Jan 22, 2026 Robins Jason Shand CFO Neutral 52.5 - 0.00% ✗ -
Jan 22, 2026 Robins Jason Shand CFO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Anderman Todd Chief Legal Officer Neutral 90.0 +64,900 74.11% ✗ -
Jan 2, 2026 Jan 6, 2026 Meyers Steve Lawrence Chief Commercial Officer Neutral 90.0 +64,900 42.49% ✗ -
Jan 2, 2026 Jan 6, 2026 Nayak Sanjay Chief Strategy Officer Neutral 90.0 +64,900 23.36% ✗ -
Jan 2, 2026 Jan 6, 2026 Kaiser Peter Chief Development Officer Neutral 90.0 +79,112 41.03% ✗ -
Jan 2, 2026 Jan 6, 2026 Saroj Namrata Chief Business Officer Neutral 90.0 +79,112 45.08% ✗ -
Jan 2, 2026 Jan 6, 2026 Waheed Nadia Chief Medical Officer Neutral 90.0 +79,112 32.01% ✗ -
Jan 2, 2026 Jan 6, 2026 Heier Jeffrey S. Chief Scientific Officer Neutral 90.0 +79,112 31.99% ✗ -
Jan 2, 2026 Jan 6, 2026 Notman Donald Officer Neutral 90.0 +79,112 25.51% ✗ -
Nov 24, 2025 Nov 26, 2025 Nayak Sanjay Chief Strategy Officer Sell 48.8 -1,878 -0.67% ✗ $22.6K
Nov 24, 2025 Nov 26, 2025 Dugel Pravin Officer Sell 45.0 -19,530 -0.56% ✗ $235.1K
Nov 24, 2025 Nov 26, 2025 Kaiser Peter Chief Development Officer Sell 46.3 -3,007 -1.55% ✗ $36.1K
Nov 24, 2025 Nov 26, 2025 Heier Jeffrey S. Chief Scientific Officer Sell 46.3 -3,469 -1.39% ✗ $41.8K
Nov 5, 2025 Nov 7, 2025 Saroj Namrata Chief Business Officer Sell 40.0 -25,865 -12.93% ✗ $277.8K
Oct 8, 2025 Oct 10, 2025 Anderman Todd Chief Legal Officer Sell 42.5 -11,132 -11.28% ✗ $137.4K
Oct 2, 2025 Oct 6, 2025 Kaiser Peter Chief Development Officer Sell 42.5 -9,653 -4.73% ✗ $106.5K
Oct 2, 2025 Oct 6, 2025 Heier Jeffrey S. Chief Scientific Officer Sell 42.5 -10,502 -4.04% ✗ $115.9K
Sep 9, 2025 Sep 11, 2025 Dugel Pravin Officer Neutral 52.5 - 0.00% ✗ -
Sep 2, 2025 Sep 4, 2025 Notman Donald Officer Sell 51.3 -1,066 -0.34% ✗ $13.3K
Aug 25, 2025 Aug 27, 2025 Kaiser Peter Chief Development Officer Sell 46.3 -3,011 -1.45% ✗ $36.3K
Aug 25, 2025 Aug 27, 2025 Nayak Sanjay Chief Strategy Officer Sell 48.8 -1,885 -0.67% ✗ $22.7K
Aug 25, 2025 Aug 27, 2025 Heier Jeffrey S. Chief Scientific Officer Sell 46.3 -3,063 -1.16% ✗ $36.9K
Aug 25, 2025 Aug 27, 2025 Dugel Pravin Officer Sell 42.5 -21,494 -0.61% ✗ $258.8K
Aug 12, 2025 Aug 14, 2025 Waheed Nadia Chief Medical Officer Neutral 90.0 +40,363 19.52% ✗ -
Apr 28, 2025 Aug 13, 2025 Dugel Pravin Officer Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Meyers Steve Lawrence Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jun 23, 2025 Saroj Namrata Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Dugel Pravin Officer Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Hong Seung Suh Director Neutral 90.0 +14,000 42.51% ✗ -
Jun 11, 2025 Jun 13, 2025 RAINES MERILEE Director Neutral 90.0 +14,000 42.51% ✗ -
Jun 11, 2025 Jun 13, 2025 LINDSTROM RICHARD L MD Director Neutral 85.0 +14,000 8.11% ✗ -
Jun 11, 2025 Jun 13, 2025 Williams Leslie J. Director Neutral 90.0 +14,000 37.40% ✗ -
Jun 11, 2025 Jun 13, 2025 Warden Charles M Director Neutral 90.0 +14,000 19.32% ✗ -
Jun 11, 2025 Jun 13, 2025 Graves Adrienne L Director Neutral 90.0 +14,000 38.89% ✗ -
Jun 2, 2025 Jun 3, 2025 Waheed Nadia Chief Medical Officer Sell 42.5 -13,861 -6.28% ✗ $111.6K
May 23, 2025 May 27, 2025 Nayak Sanjay Chief Strategy Officer Sell 48.8 -1,862 -0.66% ✗ $13.4K
May 23, 2025 May 27, 2025 Kaiser Peter Chief Development Officer Sell 46.3 -2,974 -1.42% ✗ $21.3K
May 23, 2025 May 27, 2025 Heier Jeffrey S. Chief Scientific Officer Sell 46.3 -3,024 -1.14% ✗ $21.7K
May 23, 2025 May 27, 2025 Dugel Pravin Officer Sell 45.0 -21,219 -0.60% ✗ $152.4K
May 8, 2025 May 12, 2025 LINDSTROM RICHARD L MD Director Buy 90.0 +10,000 6.15% ✗ $69.6K
Feb 24, 2025 Feb 26, 2025 Dugel Pravin Officer Sell 45.0 -21,475 -0.61% ✗ $147.5K
Feb 24, 2025 Feb 26, 2025 Heier Jeffrey S. Chief Scientific Officer Sell 46.3 -3,061 -1.14% ✗ $21K
Feb 24, 2025 Feb 26, 2025 Kaiser Peter Chief Development Officer Sell 46.3 -3,009 -1.41% ✗ $20.7K
Feb 24, 2025 Feb 26, 2025 Nayak Sanjay Chief Strategy Officer Sell 48.8 -1,895 -0.66% ✗ $13K
Feb 11, 2025 Feb 13, 2025 Dugel Pravin Officer Neutral 90.0 +2,750,000 347.31% ✗ -
Feb 11, 2025 Feb 13, 2025 Waheed Nadia Chief Medical Officer Neutral 90.0 +79,000 55.76% ✗ -
Feb 11, 2025 Feb 13, 2025 Notman Donald Officer Neutral 90.0 +115,000 59.45% ✗ -
Feb 11, 2025 Feb 13, 2025 Nayak Sanjay Chief Strategy Officer Neutral 90.0 +111,000 63.65% ✗ -
Jan 31, 2025 Feb 4, 2025 Notman Donald Officer Sell 42.5 -17,420 -8.26% ✗ $136.2K
Nov 25, 2024 Nov 27, 2024 Heier Jeffrey S. Chief Scientific Officer Sell 46.3 -2,948 -1.08% ✗ $26.6K
Nov 25, 2024 Nov 27, 2024 Kaiser Peter Chief Development Officer Sell 46.3 -2,897 -1.34% ✗ $26.1K
Nov 25, 2024 Nov 27, 2024 Nayak Sanjay Chief Strategy Officer Sell 46.3 -1,814 -1.03% ✗ $16.3K
Nov 25, 2024 Nov 27, 2024 Dugel Pravin Officer Sell 42.5 -20,680 -2.55% ✗ $186.3K
Oct 7, 2024 Oct 9, 2024 Anderman Todd Chief Legal Officer Neutral 90.0 +98,700 100.00% ✗ -
Oct 9, 2024 Anderman Todd Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Kaiser Peter Chief Development Officer Neutral 90.0 +100,000 86.22% ✗ -
Oct 2, 2024 Oct 4, 2024 Heier Jeffrey S. Chief Scientific Officer Neutral 90.0 +100,000 58.14% ✗ -
Oct 4, 2024 Kaiser Peter Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Oct 4, 2024 Heier Jeffrey S. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 29, 2024 Sep 3, 2024 Notman Donald Officer Neutral 85.0 +11,034 5.57% ✗ -
Aug 23, 2024 Aug 27, 2024 Nayak Sanjay Chief Strategy Officer Sell 46.3 -1,832 -1.03% ✗ $16.5K
Aug 23, 2024 Aug 27, 2024 Dugel Pravin Officer Sell 42.5 -20,880 -2.51% ✗ $188.3K
Feb 27, 2024 Jul 26, 2024 LINDSTROM RICHARD L MD Director Neutral 85.0 +12,000 7.96% ✗ -
Jul 24, 2024 Jul 26, 2024 Hong Seung Suh Director Neutral 90.0 +12,000 57.33% ✗ -
Jul 24, 2024 Jul 26, 2024 RAINES MERILEE Director Neutral 90.0 +12,000 57.33% ✗ -
Jul 24, 2024 Jul 26, 2024 Williams Leslie J. Director Neutral 90.0 +12,000 47.18% ✗ -
Jul 24, 2024 Jul 26, 2024 Warden Charles M Director Neutral 90.0 +12,000 19.85% ✗ -
Jul 24, 2024 Jul 26, 2024 Graves Adrienne L Director Neutral 90.0 +12,000 50.00% ✗ -
Jun 1, 2024 Jun 4, 2024 Waheed Nadia Chief Medical Officer Neutral 90.0 +141,666 100.00% ✗ -
Jun 4, 2024 Waheed Nadia Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 28, 2024 Nayak Sanjay Chief Strategy Officer Sell 46.3 -2,274 -1.26% ✗ $13.3K
May 23, 2024 May 28, 2024 Dugel Pravin Officer Sell 42.5 -21,626 -2.53% ✗ $125.2K
Feb 26, 2024 Feb 27, 2024 SUMMER ROAD LLC 10% Owner Buy 100.0 +930,851 12.15% ✗ $7M
Feb 22, 2024 Feb 26, 2024 Dugel Pravin Chair Neutral 90.0 +854,979 100.00% ✗ -
Feb 22, 2024 Feb 26, 2024 Nayak Sanjay Chief Strategy Officer Neutral 90.0 +80,300 80.30% ✗ -
Feb 26, 2024 Dugel Pravin Chair Neutral 52.5 - 0.00% ✗ -
Feb 26, 2024 Nayak Sanjay Chief Strategy Officer Neutral 52.5 - 0.00% ✗ -
Feb 3, 2024 Feb 6, 2024 White Christopher G Chief Business Officer Buy 91.3 +45,890 22.13% ✗ $28.7K
Feb 3, 2024 Feb 6, 2024 Strassburger Philip C. General Counsel Buy 91.3 +64,333 24.31% ✗ $29.3K
Feb 3, 2024 Feb 6, 2024 Ozden Rabia Gurses Chief Medical Officer Buy 91.3 +72,979 30.47% ✗ $30.8K
Feb 3, 2024 Feb 6, 2024 Notman Donald CFO Buy 91.3 +67,848 20.62% ✗ $30.2K
Feb 3, 2024 Feb 6, 2024 Mattessich Antony C. CEO Buy 95.0 +200,042 19.93% ✗ $95.5K
Jan 31, 2024 Feb 2, 2024 Notman Donald CFO Sell 46.3 -6,433 -4.40% ✗ $31.8K
Jan 31, 2024 Feb 2, 2024 Ozden Rabia Gurses Chief Medical Officer Sell 46.3 -7,764 -7.72% ✗ $38.4K
Jan 31, 2024 Feb 2, 2024 Strassburger Philip C. General Counsel Sell 46.3 -6,831 -5.89% ✗ $33.8K
Jan 31, 2024 Feb 2, 2024 White Christopher G Chief Business Officer Sell 46.3 -5,147 -5.43% ✗ $25.5K